Key Highlights
● Nasdaq notified Atlantic American on 20 August 2026 that three periodic reports remain late.
● The notice has no immediate effect on the listing or trading of the shares.
● Nasdaq had granted an extension to 12 October 2026 for the earlier reports.
● The latest published results are for the second quarter of 2025.
Atlantic American Corporation (NASDAQ:AAME), whose common stock trades on the Nasdaq Global Market under the symbol AAME, has disclosed that Nasdaq notified it on 20 August 2026 that it still falls short of Listing Rule 5250(c)(1), the requirement to file periodic reports with the Securities and Exchange Commission on time. The company announced the notice through a Form 8-K dated 26 August 2026. Three reports are involved: the annual report on Form 10-K for the year ended 31 December 2025, the quarterly report on Form 10-Q for the quarter ended 31 March 2026, and now the Form 10-Q for the quarter ended 30 June 2026. The filing states that the notice has no immediate effect on the listing or trading of the shares.
How the situation developed
This is the latest step in a sequence rather than a fresh surprise. A first notice, received on 21 May 2026 and announced the following day, concerned the overdue 2025 Form 10-K and the March quarter report. The company was required to submit a compliance plan to Nasdaq by 16 June 2026. Nasdaq subsequently granted an extension to 12 October 2026, measured as up to 180 calendar days from the original due date of the annual report. The company also lodged Form NT 10-Q notices in May and August 2026, the standard way of flagging a late quarterly report.
What the filings do and do not say
The August 8-K gives no explanation for the delay. It does not refer to a restatement, auditor change or material weakness. One automated news summary dated 15 July 2026 speculated about internal control or accounting complexity, but it described itself as possibly inaccurate and presented the cause as an open question, so it remains conjecture rather than fact. The company says only that it is making progress towards filing the delinquent reports.
Last reported results
Because no 2026 financial statements have been published, the most recent results are for the second quarter of 2025, reported in an 8-K on 12 August 2025. For the three months ended 30 June 2025, the company reported net income of US$3.3 million, or US$0.15 per diluted share, against a net loss of US$0.7 million a year earlier. Total revenue was US$55.3 million compared with US$47.7 million, and net insurance premiums were US$50.1 million compared with US$45.0 million. Non-GAAP operating income was US$1.6 million. At 30 June 2025, total assets were US$429.3 million, shareholders' equity was US$106.2 million and book value per share was US$4.94. These are historical figures, in US dollars, not guidance.
Why it matters
For an insurance holding company, timely audited accounts underpin investor and counterparty confidence, and prolonged silence leaves shareholders without current information on reserves, investment holdings and capital. The missing 2025 annual report is the central issue. A continued failure to file could eventually lead Nasdaq to begin delisting proceedings, although the company would have the right to request a hearing before a Nasdaq panel.
Three Missing Reports and a 12 October Extension Window
The August filing set 4 September 2026 as the deadline for an updated plan covering the June quarter report, with any extension for that report capped at 12 October 2026. If Nasdaq were to reject the plan, the company may appeal to a Hearings Panel. Filings available through 26 August 2026 do not show whether the delinquent reports were filed, or a further extension or panel request was made, by or after 12 October 2026.






Please wait processing your request...